Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Peonidin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 11/20 | 0.97 |
| ▸ | DPP4 | P27487 | 3/20 | 0.76 |
| ▸ | MAOA | P21397 | 1/20 | 0.76 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.70 |
| ▸ | SNCA | P37840 | 3/20 | 0.70 |
| ▸ | F2 | P00734 | 1/20 | 0.68 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.68 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.68 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | EGFR | P00533 | 2/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.57 |
| ▸ | EP300 | Q09472 | 2/20 | 0.57 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Peonidin SCHEMBL20016 | 1.00 | CD38 (0.97) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL2560105 | 0.99 | CD38 (0.95) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL20017 | 0.99 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL29394353 | 0.99 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL30891536 | 0.99 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| SCHEMBL29383042 | 0.90 | CD38 (0.85) | CD38DPP4MAOAGLO1SNCA | |
| Petunidin SCHEMBL8500875 | 0.89 | CD38 (0.82) | CD38DPP4MAOAGLO1SNCA | |
| Malvidin SCHEMBL8504053 | 0.87 | CD38 (0.83) | CD38DPP4MAOAGLO1SNCA | |
| Malvidin SCHEMBL30683334 | 0.86 | DPP4 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Malvidin SCHEMBL29640416 | 0.86 | DPP4 (1.00) | CD38DPP4MAOAGLO1SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| CN-122081377-A | Rice grain number per ear gene OsTT2 and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260124225-A1 | THERAPEUTIC COMPOSITIONS AND METHODS FOR USING SAME | KARNICK WILLIAM (US) | 2026-05-07 | — | — | US | disclosed |
| EP-3740187-B1 | INSTANTANEOUS NATURAL COLORANTS AND PROCESSES OF MAKING THE SAME | MENESES DA SILVA EDNA (FR) | 2025-12-10 | — | — | EP | disclosed |
| CN-120770489-A | Preparation method for enhancing xanthine oxidase inhibitory activity of indigo juice by lactobacillus plantarum fermentation | 东北农业大学 | 2025-10-14 | — | — | CN | disclosed |
| CN-119344452-A | Intestinal tract regulator and preparation method and application thereof | 江苏省农业科学院 | 2025-01-24 | — | — | CN | disclosed |
| CN-119278960-A | Bacillus isolates and uses thereof | 诺和新元植物生物解决方案公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-113573716-B | Treatment and prevention of infections of the herpesviridae family using delphinidin-3-glucoside | 赢创运营有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-116121269-B | Gene TrMYB118 for regulating synthesis of plant anthocyanin and application thereof | 四川农业大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-117589540-A | Blueberry freeze-dried powder standard substance containing six anthocyanidins and preparation method and application thereof | 郑少锋 | 2024-02-23 | — | — | CN | disclosed |
| CN-114763550-B | Highland barley cyanidin rhamnosyl transferase gene and application thereof | 西藏自治区农牧科学院农业研究所 | 2023-04-14 | — | — | CN | disclosed |
| CN-115901991-A | Extraction and determination method of anthocyanin in xylem of cinnabar plum stem | 北京林业大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115537286-B | Blueberry wine fermented by adding lactobacillus plantarum J26 and preparation method thereof | 东北农业大学 | 2023-03-28 | — | — | CN | disclosed |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | disclosed |
| CN-115590874-A | Application of malvidin-3-O-glucoside in preparation of medicines or health-care foods | 汤臣倍健股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-115581702-A | Application of paeoniflorin-3-O-arabinoside in preparation of medicines or health foods | 汤臣倍健股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-115537286-A | Blueberry wine fermented by adding lactobacillus plantarum J26 and preparation method thereof | 东北农业大学 | 2022-12-30 | — | — | CN | disclosed |
| CN-114250159-A | Two wild yeasts and application thereof in improving color stability of fruit wine | 中国农业大学 | 2022-03-29 | — | — | CN | disclosed |
| WO-2022052393-A1 | METHOD FOR PREPARING ACYLATED ANTHOCYANINS OF PAEONIDIN AND MALVIDIN | 浙江大学 | 2022-03-17 | — | — | WO | disclosed |
| WO-2022052393-A1 | METHOD FOR PREPARING ACYLATED ANTHOCYANINS OF PAEONIDIN AND MALVIDIN | 浙江大学 | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124225-A1 | THERAPEUTIC COMPOSITIONS AND METHODS FOR USING SAME | GCG, MC4R, GLP1R | CD38 572/4885DPP4 108/4885MAOA 1665/4885 |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | CD38 3792/4885DPP4 539/4885MAOA 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.